Open Access

Clinical application of intra-aortic balloon pump in patients with cardiogenic shock during the perioperative period of cardiac surgery

  • Authors:
    • Xuesong Jiang
    • Zhitao Zhu
    • Ming Ye
    • Yan Yan
    • Junbo Zheng
    • Qingqing Dai
    • Lianghe Wen
    • Huaiquan Wang
    • Shaofei Lou
    • Hongmei Ma
    • Pingwei Ma
    • Yunlong Li
    • Tuoyun Yang
    • Shu Zuo
    • Ye Tian
  • View Affiliations

  • Published online on: March 2, 2017     https://doi.org/10.3892/etm.2017.4177
  • Pages: 1741-1748
  • Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Intra-aortic balloon pumps (IABP) have saved many patients with cardiogenic shock during the perioperative period of cardiac surgery. However, the ideal insertion timing is controversial. In the present study, we aimed to optimize the insertion timing, in order to increase the survival rate of the patients. A total of 197 patients with cardiogenic shock during the perioperative period of cardiac surgery and implemented IABP from January 2011 to October 2015 were selected for the study. Patients were divided into five groups on the basis of application timing of IABP: 0-60, 61-120, 121-180, 181-240 and >240 min. The 30-day mortality, application rate of continuous renal replacement therapy (CRRT), duration of mechanical ventilation, duration of hospital stay and hospitalization charges were analyzed in the above groups. The risk factors related to mortality and the occurrence of IABP complications were also analyzed. The mortality in the 0-60, 61-120, 121-180, 181-240 and >240 min groups were 42.17, 36.6, 77.3, 72.7 and 79.3%, respectively. Earlier IABP insertion resulted in less patients receiving CRRT from acute renal failure and less daily hospitalization charges. However, the IABP application timing had no effect on indexes such as hospitalization duration, duration of mechanical ventilation and total hospitalization charges. Multifactor logistic regression analysis indicated that the independent risk factors of death in patients with cardiogenic shock during cardiac surgery were related to IABP support timing and vasoactive‑inotropic score (VIS) before balloon insertion. In the first 120 min of cardiogenic shock during the perioperative period of cardiac surgery, IABP application decreased 30-day mortality. Mortality was related with VIS score of patients, which can be used to predict the prognosis of patients with cardiogenic shock.
View Figures
View References

Related Articles

Journal Cover

May-2017
Volume 13 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

The Cancer Story
Copy and paste a formatted citation
x
Spandidos Publications style
Jiang X, Zhu Z, Ye M, Yan Y, Zheng J, Dai Q, Wen L, Wang H, Lou S, Ma H, Ma H, et al: Clinical application of intra-aortic balloon pump in patients with cardiogenic shock during the perioperative period of cardiac surgery. Exp Ther Med 13: 1741-1748, 2017
APA
Jiang, X., Zhu, Z., Ye, M., Yan, Y., Zheng, J., Dai, Q. ... Tian, Y. (2017). Clinical application of intra-aortic balloon pump in patients with cardiogenic shock during the perioperative period of cardiac surgery. Experimental and Therapeutic Medicine, 13, 1741-1748. https://doi.org/10.3892/etm.2017.4177
MLA
Jiang, X., Zhu, Z., Ye, M., Yan, Y., Zheng, J., Dai, Q., Wen, L., Wang, H., Lou, S., Ma, H., Ma, P., Li, Y., Yang, T., Zuo, S., Tian, Y."Clinical application of intra-aortic balloon pump in patients with cardiogenic shock during the perioperative period of cardiac surgery". Experimental and Therapeutic Medicine 13.5 (2017): 1741-1748.
Chicago
Jiang, X., Zhu, Z., Ye, M., Yan, Y., Zheng, J., Dai, Q., Wen, L., Wang, H., Lou, S., Ma, H., Ma, P., Li, Y., Yang, T., Zuo, S., Tian, Y."Clinical application of intra-aortic balloon pump in patients with cardiogenic shock during the perioperative period of cardiac surgery". Experimental and Therapeutic Medicine 13, no. 5 (2017): 1741-1748. https://doi.org/10.3892/etm.2017.4177